---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-23-003939"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2023-12-19T23:59:59+00:00"
generated_at: "2026-06-07T10:34:17.807010+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ReWalk granted Nasdaq compliance extension to March 30, 2024 citing CMS rule catalyst

## Summary
- Panel extended bid price compliance deadline from Jan 31 to March 30, 2024.
- Must close at $1.00+ for 10 consecutive business days by March 30, 2024.
- Extension sought to allow CMS to finalize home health rule including exoskeletons in Medicare.
- Company may implement reverse stock split to maintain Nasdaq listing if needed.
- Risk of delisting remains if compliance not achieved by extended deadline.

## SEC filing metadata
- accession: 0001178913-23-003939
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2023-12-19T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891323003939/0001178913-23-003939-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891323003939/zk2330673.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-23-003939
- JSON: https://secwatch.observer/filing/0001178913-23-003939.json
- Plain text: https://secwatch.observer/filing/0001178913-23-003939.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.